Trinity Biotech (TRIB) EBT Margin Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) EBT Margin Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -8,719.00 |
| Sep 30, 2024 | -3,892.00 |
| Jun 30, 2024 | -4,298.00 |
| Mar 31, 2024 | -3,886.00 |
| Dec 31, 2023 | -7,240.00 |
| Sep 30, 2023 | -7,656.00 |
| Jun 30, 2023 | -14,488.00 |
| Mar 31, 2023 | -5,655.00 |
| Dec 31, 2022 | -7,891.00 |
| Sep 30, 2022 | -7,552.00 |
| Jun 30, 2022 | -7,791.00 |
| Mar 31, 2022 | -9,661.00 |
| Dec 31, 2021 | -2,438.00 |
| Sep 30, 2021 | -484.00 |
| Jun 30, 2021 | -1,363.00 |
| Mar 31, 2021 | 344.00 |
| Dec 31, 2020 | 2,003.00 |
| Sep 30, 2020 | 1,948.00 |
| Jun 30, 2020 | -230.00 |
| Mar 31, 2020 | 268.00 |